knowledge -WSS

knowledge

author：Wikipedia 2025-09-27 12:55:00 - browse：512

Joaquin Duato -- health policy coverage from STAT — Johnson & Johnson CEO Joaquin Duato MICHAEL BUHOLZER/AFP via Getty Images

WASHINGTON — Merck CEO Robert Davis and Johnson & Johnson CEO Joaquin Duato have agreed to voluntarily testify before the Senate health committee, avoiding a threatened subpoena, the committee announced Friday.

The decision by the executives came after a public pressure campaign by Sanders to get the two executives and Bristol Myers Squibb CEO Chris Boerner to testify about why prices for their drugs are higher in the United States than in other countries. Sanders had scheduled a vote to subpoena the Merck and Johnson & Johnson CEOs on Jan. 31, but canceled it on Friday.

“The use of a subpoena was clearly a last resort and I’m delighted that these CEOs will be coming into our committee voluntarily,” Sanders said in a written statement.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Activists slam private health insurers over coverage restrictions
Next article： In his State of the Union, Biden takes clear aim at 'Big Pharma'

WSS

Headspace, Meta partner to launch VR meditation app for Quest

Eli Lilly, Pfizer, and others want in on the online prescription market

Humana cuts profit projections as Medicare Advantage costs soar

CDC marks new Covid

The drug industry has found itself all alone in Washington

RSV shot was 90% effective at preventing hospitalizations in kids

hotspot

knowledge

focus

Continuity nursing helped my family in our darkest PICU moments

Copay coupons to count toward deductibles, after Biden court move

Wildfire smoke exposes gaps in outdoor worker protections

In his State of the Union, Biden takes clear aim at 'Big Pharma'

Sports medicine is finally prioritizing gender equality

First medicine developed to treat MASH expected to be approved soon

Duchenne breakthrough therapy leaves behind pioneering families

Readout Newsletter: BridgeBio, Madrigal, and Silicon Valley Bank

How one medical school became remarkably diverse

NEJM study link tiny plastics in blood vessels to heart problems

focus

In his State of the Union, Biden takes clear aim at 'Big Pharma'

Change Healthcare cyberattack prompts Medicare loan program

First medicine developed to treat MASH expected to be approved soon

Former medical device CEO who sold dummy, plastic parts convicted of fraud

Change Healthcare cyberattack prompts Medicare loan program

NEJM study link tiny plastics in blood vessels to heart problems

focus

hotspot

Wikipedia

explore